Biogen Halts Studies of Closely Watched Alzheimer's Drug, a Blow to Hopes for New Treatment

The last Posts from Scientific American

• The Dawn of Self-Consciousness
• And Now, the Really Big Coal Plants Begin to Close
• An Innovative Robotic Exosuit Boosts Both Walking and Running
• A Flash on Jupiter, the Death of Mitochondria and the World under Your Skin: The Week's Best Science GIFs
• The Reason Antarctica Is Melting: Shifting Winds, Driven by Global Warming
• Your Employer May Be Spying on You-and Wasting Its Time
• Astronomers Closer to Cracking Mystery of Fast Radio Bursts
• Scientists Seek Better Guidelines for Editing Genes in Human Embryos
• A Swiss Army Knife for Your Mind
• Whistle-Blower Complaint Highlights CDC Turmoil on Climate
• Companies May Limit Lifesaving Climate Data to Clients That Can Pay
• Can We Rely on Our Intuition?
• Bridging a Binary Universe
• Whistleblower Complaint Highlights CDC Turmoil on Climate
• Space Dust from Ancient Supernova Found Hiding in Antarctica
• Secrets of the Universe Trapped in Antarctic Snow
• Why Are Deepfakes So Effective?
• Certain Personality Types Are Likely to Make a "Foodie Call"
• When Will All the Ice in the Arctic be Gone?
• A Scientist Must Go Where the Evidence Leads